-
Most Recent
Cannabis Stocks
Cannabis is a psychoactive drug that is a part of the Cannabacaee plant family. In the past few years, acceptance of the drug has risen dramatically. Industry leaders, like Canopy Growth and Curaleaf, are quickly establishing the framework for legal cannabis sales. THC is believed to be the component in cannabis that creates the psychoactive effect, which can be used to treat depression, anxiety, sleeping problems, and a wide range of other issues.
3 Cannabis Stocks That Can Be Massive Wealth Creators by 2030
These are the cannabis stocks to buy as they represent companies with improving fundamentals and accelerated growth outlook.
7 Growth Stocks That Could 7X in the Next 7 Years
Investors consider these growth stocks to buy since they represent companies with good fundamentals and a positive industry outlook.
3 Cannabis Stocks to Sell in August Before They Crash & Burn
Marijuana could be a major industry in the U.S. if it was legalized but these cannabis stocks to sell have other problems to contend with.
Other industries you might be interested in
Recent Cannabis Stocks Articles
We’ve Reached the Must-Hold Support Point for Aurora Cannabis Stock
Aurora Cannabis has been decimated. It has a potentially tradable bottom, but there's not much to love about ACB stock now.
Aurora Cannabis Stock Needs Some Christmas Magic
So far, pot smokers don't want to give their money to the legal side of the business. For investors, that means ACB stock is a name to avoid.
Canopy Growth Stock Can Climb, But How Much Is Debatable
Canopy Growth stock has been caught up in the slump affecting all marijuana stocks, but CGC appears sturdier than its rivals.
Two Key Reasons Not to Buy the Dip in Canopy Growth Stock
Near the lows, CGC stock might look tempting. But investors should keep two troublesome factors in mind when it comes to Canopy Growth stock.
Don’t Count on Altria to Keep the Price of Cronos Stock Propped Up
Cronos stock is severely overvalued and is likely to fall further. Cronos is more expensive than any other Canadian cannabis stock, even despite the recent Altria investment
Aurora Cannabis Stock Still Offers Long-Term Growth Opportunity
The downgrades and the pullback in ACB stock have led to overkill. The stock is now obscenely oversold at double-bottom support.
Has Aurora Cannabis Stock Finally Bottomed Out?
With the Canadian recreational cannabis market finally gaining some steam, is ACB stock poised to recover from its seven-month slump?
4 Key Players Just Held a Marijuana Summit
The governors of four important U.S. states just got together to discuss marijuana legalization. Now's the time to get in cannabis stocks!
Friday’s Vital Data: Intel, Tesla and Cronos Group
Options trading was hot in Intel, Tesla and Cronos Group stocks on Thursday. Here’s what the data suggests moving forward.
Aphria Stock Looks Like the Best Cannabis Play Right Now
Aphria stock, like other cannabis stocks, has plunged. But while risks remain, APHA stock looks attractive here.
Canopy Growth Stock Is the Best Card in a Bad Hand of Cannabis Stocks
CGC has the cash to wait for marijuana's full legalization, thanks to majority owner Constellation Brands.
Black Market Weed Hurts Struggling Canopy Growth Stock
Some investors have focused on Canopy's lawsuit with Go Farm Hemp. But there's a much bigger issue plaguing CGC stock at the moment.
Lift a Glass to Legal Cannabis’ Next Big Trend — and Opportunity
Legalization 2.0 in Canada will soon start to show us what cannabis products consumers like, and which ones will be weeded out (pun intended).
Aurora Cannabis Stock Is Still Not Worth a Buy
If history repeats itself, ACB stock could lead the bulls to big-time profits. But there’s still plenty of work to be done before Aurora Cannabis is buy-worthy.
Marijuana REIT Innovative Industrial Properties Grows With LivWell Deal
IIPR stock has a foothold in one of the fastest-growing industries -- marijuana. If you can stomach some volatility, IIPR is a smart choice.
Investors Should Jump Into Cronos Group Stock’s Mystery Moves
CRON stock is not for the faint of heart. Do you think you have what it takes to profit from this pot powerhouse?
Aurora Cannabis Stock: The Worst Is Yet to Come
ACB stock has taken a beating in the past year. Unfortunately, a fully supplied Canadian market coupled with a looming debt payment likely means more troubles ahead for Aurora stock.
Shareholders Worry as Tilray Stock Approaches IPO Price
If Tilray stock breaks the $17 level, the IPO price will become a resistance level. Investors should also expect short selling there.
Investors Beware: Tilray Stock Might Not Be Done Dropping
Tilray stock probably has further to fall since TLRY must overcome further funding obstacles before it can become a profitable company.
